n. 1 junior grant:“Assessment of anti-cancer therapy using immunocytokines and immune checkpoint inhibitors combined with oncosuppressor RNASET2 in immunocompetent mouse models”(dbsv2022-adrj001)
n. 1 junior grant:“Assessment of anti-cancer therapy using immunocytokines and immune checkpoint inhibitors combined with oncosuppressor RNASET2 in immunocompetent mouse models”(dbsv2022-adrj001)
A selection procedure by qualifications is hereby opened for the assignment of n. 1 junior research grants with a duration of 1 year.
Research Title: “Assessment of anti-cancer therapy using immunocytokines and immune checkpoint inhibitors combined with oncosuppressor RNASET2 in immunocompetent mouse models”.
All the details in the announcement.
Calling Code: dbsv2022-adrj001
Official Publication Date: 27 July 2022
Published on the MIUR website: 27 July 2022